Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.

Andor N, Graham TA, Jansen M, Xia LC, Aktipis CA, Petritsch C, Ji HP, Maley CC.

Nat Med. 2016 Jan;22(1):105-13. doi: 10.1038/nm.3984. Epub 2015 Nov 30.

2.

Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.

Morris LG, Riaz N, Desrichard A, ┼×enbabao─člu Y, Hakimi AA, Makarov V, Reis-Filho JS, Chan TA.

Oncotarget. 2016 Mar 1;7(9):10051-63. doi: 10.18632/oncotarget.7067.

3.

Genomic Instability in Cancer: Teetering on the Limit of Tolerance.

Andor N, Maley CC, Ji HP.

Cancer Res. 2017 May 1;77(9):2179-2185. doi: 10.1158/0008-5472.CAN-16-1553. Epub 2017 Apr 21. Review.

4.

Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer.

Kim TM, Jung SH, Baek IP, Lee SH, Choi YJ, Lee JY, Chung YJ, Lee SH.

J Pathol. 2014 Aug;233(4):425-35. doi: 10.1002/path.4380.

PMID:
24870262
5.

Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.

Ma D, Jiang YZ, Liu XY, Liu YR, Shao ZM.

Breast Cancer Res Treat. 2017 Feb;162(1):39-48. doi: 10.1007/s10549-017-4113-z. Epub 2017 Jan 16.

PMID:
28093659
6.

Multi-region and single-cell sequencing reveal variable genomic heterogeneity in rectal cancer.

Liu M, Liu Y, Di J, Su Z, Yang H, Jiang B, Wang Z, Zhuang M, Bai F, Su X.

BMC Cancer. 2017 Nov 23;17(1):787. doi: 10.1186/s12885-017-3777-4.

7.

Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.

Kim TM, Jung SH, An CH, Lee SH, Baek IP, Kim MS, Park SW, Rhee JK, Lee SH, Chung YJ.

Clin Cancer Res. 2015 Oct 1;21(19):4461-72. doi: 10.1158/1078-0432.CCR-14-2413. Epub 2015 May 15.

8.

A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.

Stanta G, Bonin S.

Pathobiology. 2018;85(1-2):7-17. doi: 10.1159/000477813. Epub 2017 Jul 28.

PMID:
28750401
9.

Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.

McBride M, Rida PC, Aneja R.

Mol Aspects Med. 2015 Nov;45:3-13. doi: 10.1016/j.mam.2015.05.001. Epub 2015 May 27. Review.

10.

Pan-cancer inference of intra-tumor heterogeneity reveals associations with different forms of genomic instability.

Raynaud F, Mina M, Tavernari D, Ciriello G.

PLoS Genet. 2018 Sep 13;14(9):e1007669. doi: 10.1371/journal.pgen.1007669. eCollection 2018 Sep.

11.

Intra-tumor genetic heterogeneity in rectal cancer.

Hardiman KM, Ulintz PJ, Kuick RD, Hovelson DH, Gates CM, Bhasi A, Rodrigues Grant A, Liu J, Cani AK, Greenson JK, Tomlins SA, Fearon ER.

Lab Invest. 2016 Jan;96(1):4-15. doi: 10.1038/labinvest.2015.131. Epub 2015 Nov 16.

12.

A Systematic Pan-Cancer Analysis of Genetic Heterogeneity Reveals Associations with Epigenetic Modifiers.

de Matos MR, Posa I, Carvalho FS, Morais VA, Grosso AR, de Almeida SF.

Cancers (Basel). 2019 Mar 20;11(3). pii: E391. doi: 10.3390/cancers11030391.

13.

Measuring intratumor heterogeneity by network entropy using RNA-seq data.

Park Y, Lim S, Nam JW, Kim S.

Sci Rep. 2016 Nov 24;6:37767. doi: 10.1038/srep37767.

14.

Intratumor heterogeneity: evolution through space and time.

Swanton C.

Cancer Res. 2012 Oct 1;72(19):4875-82. doi: 10.1158/0008-5472.CAN-12-2217. Epub 2012 Sep 20. Review.

15.

Intratumor heterogeneity: nature and biological significance.

Gerashchenko TS, Denisov EV, Litviakov NV, Zavyalova MV, Vtorushin SV, Tsyganov MM, Perelmuter VM, Cherdyntseva NV.

Biochemistry (Mosc). 2013 Nov;78(11):1201-15. doi: 10.1134/S0006297913110011. Review.

PMID:
24460935
16.

Pan-cancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures.

Kikutake C, Yoshihara M, Sato T, Saito D, Suyama M.

Oncotarget. 2018 Dec 28;9(102):37689-37699. doi: 10.18632/oncotarget.26485. eCollection 2018 Dec 28.

17.

Estimation of tumor heterogeneity using CGH array data.

Wang K, Li J, Li S, Bolund L, Wiuf C.

BMC Bioinformatics. 2009 Jan 9;10:12. doi: 10.1186/1471-2105-10-12.

18.

Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.

Beltran H, Eng K, Mosquera JM, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J, Park K, Banfelder J, Prandi D, Madhukar N, Zhang T, Padilla J, Greco N, McNary TJ, Herrscher E, Wilkes D, MacDonald TY, Xue H, Vacic V, Emde AK, Oschwald D, Tan AY, Chen Z, Collins C, Gleave ME, Wang Y, Chakravarty D, Schiffman M, Kim R, Campagne F, Robinson BD, Nanus DM, Tagawa ST, Xiang JZ, Smogorzewska A, Demichelis F, Rickman DS, Sboner A, Elemento O, Rubin MA.

JAMA Oncol. 2015 Jul;1(4):466-74. doi: 10.1001/jamaoncol.2015.1313.

19.

Breast cancer intratumor genetic heterogeneity: causes and implications.

Ng CK, Pemberton HN, Reis-Filho JS.

Expert Rev Anticancer Ther. 2012 Aug;12(8):1021-32. doi: 10.1586/era.12.85. Review.

PMID:
23030222
20.

PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors.

Deshwar AG, Vembu S, Yung CK, Jang GH, Stein L, Morris Q.

Genome Biol. 2015 Feb 13;16:35. doi: 10.1186/s13059-015-0602-8.

Supplemental Content

Support Center